NCT04298411

Brief Summary

This study seeks to 1) adapt a low-cost controller, the Novint Falcon, and a set of video games that would provide rehabilitative feedback for young people with cerebral palsy, and 2) explore feasibility of the Falcon system and it's effect on upper limb and hand function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 6, 2020

Completed
Last Updated

March 6, 2020

Status Verified

December 1, 2019

Enrollment Period

2.8 years

First QC Date

January 29, 2020

Last Update Submit

March 4, 2020

Conditions

Keywords

haptic feedbackNovint Falconupper limb motor functionrehabilitationmotor learningneuroplasticityvideo games

Outcome Measures

Primary Outcomes (1)

  • Change in Canadian Occupational Performance Measure (COPM)

    The Canadian Occupational Performance Measure evaluates changes in perceived function and satisfaction of performance in self-identified goal areas. The child and parent work together with the therapist to identify 1-3 goals of interest. For each goal area, the child/parent ranks its importance, performance and satisfaction on a scale of 1-10. A higher rating indicates a more positive outcome.

    Measured at 0 weeks (pre-intervention) and 12 weeks (post-intervention).

Secondary Outcomes (5)

  • Change in Grip Strength

    Measured at 0 weeks (pre-intervention) and 12 weeks (post-intervention).

  • active/passive range of motion

    Measured at 0 weeks (pre-intervention) and 12 weeks (post-intervention).

  • Change in Children's Hand-use Experience Questionnaire (CHEQ)

    Measured at 0 weeks (pre-intervention) and 12 weeks (post-intervention).

  • Change in Shortened Physical Activity Enjoyment Scale (S-PACES)

    Measured at 1 week, 6 weeks, and 12 weeks.

  • Change in the answers reported in custom feedback questionnaires

    Measured at 1 week, 6 weeks, and 12 weeks.

Study Arms (1)

Experimental Arm

EXPERIMENTAL

Participants will take part in 12 one-hour rehabilitation sessions over 12 weeks in the clinic at Holland Bloorview Kids Rehabilitation Hospital and Institut de réadaptation en déficience physique de Québec, during which they will play games developed for the Novint Falcon.

Device: Falcon

Interventions

FalconDEVICE

The Falcon contains a selection of 25+ games that require wrist extension and challenges children to grasp the controller with their affected hand. As children progress, they may advance to more difficult games that challenge the child to work against a resistance and/or apply greater grip forces. Therapists will be trained on the system, games, and given a guide summarizing the available games and the motor function areas targeted in the game. Using this guide, therapists can choose the games that are most suited to the child's abilities and goals. As multiple games will target many of the same motor function areas, children will have the option of choosing the games they like best to maximize motivational value. While this introduces some variability in the intervention, this flexibility is required to ensure that the therapy is targeting the specific interests, needs and goals of each individual child and is reflective of how ICP is used in a clinic setting.

Experimental Arm

Eligibility Criteria

Age7 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of hemiplegic cerebral palsy
  • Level I to III on the Manual Abilities Classification System (MACS)
  • Ability to understand and communicate in English (Holland Bloorview site) or French (IRDPQ site) at a grade 2 level or higher

You may not qualify if:

  • Received Botulinum Toxin in the most recent 3 months
  • History of epilepsy
  • Past experience of an injury or disability that would render therapy unsafe
  • Visual, cognitive or auditory disabilities that interfere with the ICP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Holland Bloorview Kids Rehabilitation Hospital

Toronto, Ontario, M4G 1R8, Canada

Location

Centre interdisciplinaire de recherche en réadaptation et en intégration sociale

Québec, G1M 2S8, Canada

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Elaine Biddiss, PhD

    Holland Bloorview Kid's Rehabilitation Hospital

    PRINCIPAL INVESTIGATOR
  • Jean-Sébastien Roy, PT, PhD

    Laval University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2020

First Posted

March 6, 2020

Study Start

January 1, 2016

Primary Completion

October 30, 2018

Study Completion

June 1, 2019

Last Updated

March 6, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

No IPD sharing plans.

Locations